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Abstract
Thy-1 is a membrane glycoprotein suggested to stabilize or inhibit growth of neuronal processes. However, its precise
function has remained obscure, because its endogenous ligand is unknown. We previously showed that Thy-1 binds directly
to aVb3 integrin in trans eliciting responses in astrocytes. Nonetheless, whether aVb3 integrin might also serve as a Thy-1-
ligand triggering a neuronal response has not been explored. Thus, utilizing primary neurons and a neuron-derived cell line
CAD, Thy-1-mediated effects of aVb3 integrin on growth and retraction of neuronal processes were tested. In astrocyte-
neuron co-cultures, endogenous aVb3 integrin restricted neurite outgrowth. Likewise, aVb3-Fc was sufficient to suppress
neurite extension in Thy-1(+), but not in Thy-1(2) CAD cells. In differentiating primary neurons exposed to aVb3-Fc, fewer
and shorter dendrites were detected. This effect was abolished by cleavage of Thy-1 from the neuronal surface using
phosphoinositide-specific phospholipase C (PI-PLC). Moreover, aVb3-Fc also induced retraction of already extended Thy-
1(+)-axon-like neurites in differentiated CAD cells as well as of axonal terminals in differentiated primary neurons. Axonal
retraction occurred when redistribution and clustering of Thy-1 molecules in the plasma membrane was induced by aVb3
integrin. Binding of aVb3-Fc was detected in Thy-1 clusters during axon retraction of primary neurons. Moreover, aVb3-Fc-
induced Thy-1 clustering correlated in time and space with redistribution and inactivation of Src kinase. Thus, our data
indicates that aVb3 integrin is a ligand for Thy-1 that upon binding not only restricts the growth of neurites, but also induces
retraction of already existing processes by inducing Thy-1 clustering. We propose that these events participate in bi-
directional astrocyte-neuron communication relevant to axonal repair after neuronal damage.
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Introduction
Thy-1 is a small, highly conserved, glycosyl phosphatidylinositol
(GPI)-anchored surface protein that is present on many cells, such
as fibroblasts, ovarian cells, lymphocytes, cancer cells and neurons
[1]. In the central nervous system (CNS), high levels of Thy-1
expression are reached during the first postnatal weeks in chicken,
rat, mouse, dog, and humans [2,3]. Despite its conserved and
widespread expression, the role of neuronal Thy-1 has remained
poorly defined.
Historically, Thy-1 has been suggested to function as an
inhibitor of neurite outgrowth in vitro. For instance, cells of neural
origin, like PC12 and NG115, increase the extension of neuronal-
like processes when lacking Thy-1 [4,5]. Recently, Thy-1-
mediated inhibition of neurite outgrowth was suggested to impair
neuronal regeneration in vivo [6–8]. Indeed, a decrease in Thy-1
levels might be required in regeneration of dorsal root ganglion
neurons following injury of the sciatic nerve in adult rats [6]. Part
of the ‘‘scientific facelessness’’ of Thy-1 stems from the lack of a
defined ligand [1]. Hence, studies employing anti-Thy-1 antibod-
ies have prevailed to characterize signaling events triggered by
Thy-1.
Anti-Thy-1 antibodies have additionally been used to study
changes in Thy-1 mobility on cell membranes and downstream
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intracellular signaling [9]. Due to its GPI anchor, Thy-1 mobility
has been found to be higher than that of transmembrane proteins
[10] and highly dynamic changes in lateral diffusion, as well as
clustering of Thy-1 in cholesterol-rich micro-domains are thought
to trigger Src-dependent downstream signaling events [9,11,12].
Interestingly, a mechanism that explains how Thy-1-dependent
Src-mediated signaling may be achieved by coupling the events
occurring in the outer-leaflet with those in the inner-leaflet of the
plasma membrane has been previously proposed [11,12].
Importantly, such events have not been evaluated using an
endogenous ligand for Thy-1.
We have previously shown that endogenous Thy-1, expressed
on neuronal cell lines, or recombinant Thy-1-Fc protein, directly
binds to aVb3 integrin in trans and triggers a variety of downstream
signaling events that lead to focal adhesion and stress fiber
formation in DITNC1 astrocytes [13–18]. Thus, aVb3 integrin is a
receptor for Thy-1 that induces morphological changes in
astrocytes. Although, the potential consequences of Thy-1-aVb3
integrin interaction for neurons have been suggested
[1,13,14,17,18], these have never been formally shown.
Here, astrocytic aVb3 integrin was evaluated as a possible ligand
for Thy-1 and changes in neurons were assessed. We provide
evidence indicating that inhibition of neurite outgrowth is
mediated by Thy-1-aVb3 integrin interaction in neuron-astrocyte
co-cultures. Moreover, aVb3-Fc triggered retraction of already
established neuronal processes and clustering of Thy-1 on
neuronal cell membranes. Thy-1 clustering coincided time-wise
with a co-distribution of Thy-1 and Src kinase, as well as with
increased Src phosphorylation on Tyrosine-527, a marker for
kinase inactivation. These observations support a model whereby
astrocytic aVb3 integrin operates as a Thy-1-ligand that triggers
neuronal alterations through the engagement of Thy-1. Thus,
Thy-1-aVb3 integrin association represents a novel bidirectional
signaling module that connects neurons with astrocytes.
Materials and Methods
Cells, peptides and enzymes
CAD cells, semi-adherent immortalized cells derived from
cathecolaminergic neurons of mouse CNS, were kindly donated by
Dr. Donna Chikaraishi (Duke University Medical Center NC,
USA) [19]..The DINTC1 astrocyte cell line was obtained from Dr.
Luc Pellerin (University of Lausanne, Switzerland). All cell lines
were cultured following reported conditions [17]. Purified primary
neurons were derived from brain cortices of 16 day-old rat
embryos following published protocols [20] and cultured on poly-
L-lysine-coated glass coverslips in 0.5 ml of Neurobasal supple-
mented with B27, 1% penicillin-streptomycin, and 1 mM
glutamine (Gibco). Neurons cultured during 4–5 days were
employed for dendrite outgrowth assays. Alternatively, those of
12–15 days were used to study the retraction of neuronal processes
and Thy-1 clustering. All procedures used to obtain primary cells
were revised and approved by the local Bioethics Committee for
Animal Experimentation, Faculty of Medicine, Universidad de
Chile (protocol CBA #0259). PI-PLC was purchased from Sigma.
Recombinant Fc molecules and their characterization have been
previously reported [17].
Thy-1 knockdown
We generated stable cells with reduced levels of Thy-1 using
methods previously described [21,22] by targeting Thy-1 mRNA
with four different shRNA using the lentiviral expression vector
pLKO.1 and puromycin selection. Targeted sequences were:
shRNA1 59-CCGCCATGAGAATAACACCAA-39; shRNA2 59-
CAGCCCTATATCAAGGTCCTT-39; shRNA3 59-TGAGAA-
TAACACCAAGGATAA-39; shRNA4 59-GTATAGAGA-
CAAGCTGGTCAA-39. As control, an shRNA against the
luciferase gene was employed. Constructs were generated by
The Broad Institute (Boston, MA) based on different criteria for
shRNA design (see http://www.broadinstitute.org/rnai/trc/lib).
Morphological differentiation of CAD cells
In all experiments where CAD wild type Thy-1(+) (CAD cells),
CAD shRNA Thy-1(2) or CAD shRNA control Thy-1(+) cells
were differentiated, the cells were detached by gentle pipetting
with 5 ml of PBS, counted and seeded over different substrates for
24 hours in DMEM/F12, 8% FBS, and 1% penicillin-streptomy-
cin. Next day, complete medium was removed, cells were washed
with abundant PBS and serum-free medium supplemented with
50 ng/ml SeNa during 1, 24 or 72 hours was added. This
procedure reduces the proliferation rate and induces morpholog-
ical, as well as functional differentiation [19].
Neurite outgrowth on astrocytes
CAD-DITNC1 co-cultures were employed to study neuron-
astrocyte communication in vitro [17]. Briefly, DITNC1 astrocytes
were grown to 60% confluency on 6-well plastic plates in DMEM/
F12, 8% FBS, and 1% penicillin-streptomycin. Then, 86104
neuronal CAD cells were added to astrocyte monolayers. Next
day, cells were washed with PBS and differentiation of CAD cells
in serum-free medium was induced for 24 hours. In other
experiments, 90% confluent astrocyte monolayers were fixed with
4% p-formaldehyde in 100 mM PIPES pH 6.8, 0.04 M KOH,
2 mM EGTA and 2 mM MgCl2 for 15 minutes at room
temperature and washed with abundant PBS. Then, fixed
monolayers were incubated with Thy-1-Fc or TRAIL-R2-Fc
recombinant proteins (600 ng/ml) or with anti-b3 integrin (clone
F11, Pharmingen) or anti-b1 integrin (clone Ha2/5, Beckton &
Dickinson) antibodies (5 mg/ml) during 1 hour. Next, CAD cells
were added and differentiated in serum-free medium as mentioned
before. Fixed-cell DIC images were acquired by using a Nikon
eclipse E600FN microscope with water immersion 406 (1.2 NA)
and 606 (1.4 NA) objectives.
Neurite outgrowth on aVb3-Fc-coated plates
For each independent experiment, plastic plates were coated
with control or aVb3-Fc supernatants for 48 hours. After that,
each matrix was incubated with PBS supplemented or not with
anti-aV integrin and anti-b3 integrin or with the equivalent
amount of anti-b1 integrin antibodies at room temperature for
15 minutes. Then, solutions containing antibodies were discarded
and the plates were washed twice with PBS. CAD, CAD shRNA
Thy-1(2) or CAD shRNA control Thy-1(+) cells were seeded over
the different matrices in complete medium overnight. Next,
neuronal-like differentiation was induced by serum deprivation for
24 hours. After differentiation, cells were fixed and photographed
as indicated before.
Dendrite outgrowth in presence of soluble aVb3-Fc
Cortical neurons (4–5 days in culture) were treated daily with
aVb3-Fc-containing supernatants (1:10) for 3 days. As a control,
aVb3-Fc-depleted supernatants, obtained by overnight incubation
with 1 mg/ml of Protein A-coated beads at 4uC, was used.
Integrin aVb3-Fc was no longer detected in depleted-supernatants
by Western blot analysis (not shown). As an additional control,
aVb3-Fc-depleted supernatants containing 8.8 mg/ml of purified
TRAIL-R2-Fc [13,18] were also used. In some cases, neurons
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were pre-treated with 1 U/ml of PI-PLC following a previously
reported protocol [4]. As a control, cells were incubated with heat-
inactivated PI-PLC. After the different treatments, neurons were
fixed and stained with antibodies to MAP-2. Images were acquired
using a Nikon eclipse E600FN microscope with water immersion
606 (1.4 NA) objective.
Neurite retraction and live cell monitoring
CAD wt (46104) cells were seeded in 3.5 cm plastic plates in
complete medium overnight and subsequently left to differentiate
for 24 hours in serum-free medium as indicated before. To initiate
live cell monitoring, cell medium was replaced by a solution
containing 145 mM NaCl, 5 mM KCl, 2 mM CaCl2, 1 mM
MgCl2, 10 mM glucose and 10 mM HEPES, pH 7.4 and
300 mOsm. Then, control supernatants or aVb3-Fc-containing
supernatants were added after diluting them 1-to-10 fold.
Morphological changes were recorded during 75 minutes. In
other experiments, CAD wt (26104) cells were seeded on glass
coverslips in 24-well plates with complete medium and incubated
overnight. Afterwards, differentiation was induced for 24 hours
and cells were then exposed to control supernatants or aVb3-Fc-
containing supernatants for 75 minutes. Cells were fixed and
stained with anti-Thy-1 antibodies and rhodamine-conjugated
phalloidin to visualize polymerized actin.
Neuronal process retraction and Thy-1 clustering assays
Differentiated cortical neurons, 12–15 days in culture in vitro,
were treated with supernatants containing aVb3-Fc fusion protein
or with control aVb3-Fc-depleted supernatants supplemented or
not with 8.8 mg/ml of TRAIL-R2-Fc fusion protein or with
0.1 mg/ml of Protein A for 0, 15, 30 or 60 minutes (Thy-1
clustering evaluation) or 24 hours (process retraction). After these
treatments, neurons were fixed and stained with antibodies against
Thy-1.
Immunostaining
To analyze neurite retraction, CAD cells were fixed with 4% p-
formaldehyde in 100 mM PIPES buffer, pH 6.8, containing
0.04 M KOH, 2 mM EGTA, and 2 mM MgCl2, permeabilized
with 0.1% Triton X-100 in PBS containing 1 mM sodium
orthovanadate and aprotinin, leupeptin, and benzamidine
(10 mg/ml each) for 10 min, and blocked with 1% bovine serum
albumin in PBS for 15 minutes. Then, cells were stained with anti-
Thy-1 antibodies (1:200 clone III5 [17,23]), which were detected
with FITC-conjugated secondary antibody. Rhodamine-conjugat-
ed phalloidin (1:2000) was used to detect F-actin. After washing
and mounting the coverslips with Mowiol-2.5% 1,4-Diazabicyclo
[2.2.2]octane, fluorophores were visualized in a Zeiss LSM-Pascal
5 confocal microscope. Inhibition of dendrite outgrowth of cortical
neurons was analyzed by fixing, permeabilizing with 0.1% Triton
X-100, and staining with anti-MAP-2 antibodies (1:1000) followed
by a FITC-conjugated secondary antibody (1:1000).
To study Thy-1 clustering, cortical neurons were fixed with 4%
p-formaldehyde in HBSS buffer (Gibco). Next, neurons were
washed with a solution containing 10% bovine fetal serum and
0.1 mM glycine in HBSS four times for 5 minutes. Staining was
performed with mouse anti-Thy-1 antibody for 20 minutes (1:200
clone OX7, Millipore) followed by Alexa 488-conjugated
secondary antibody (1:1000). Under these conditions, fixation-
induced membrane permeabilization was minimal (Fig. S1). To
study aVb3-Fc/Thy-1 co-localization, neurons stained for Thy-1
were then incubated in the presence or the absence of
supernatants containing aVb3-Fc for 15 minutes, washed well
with PBS and fixed with 4% p-formaldehyde in HBSS buffer.
Bound aVb3-Fc was detected using consecutive incubations with a
goat anti-human IgG antibody (1:1000) and a donkey anti-goat
IgG Cy3-conjugated antibody (1:1000). Fluorescence was visual-
ized by using a Zeiss AXIO Imager A2 microscope with a 636
objective (1.4 NA).
Western blot of Src kinase
Neurons (46105) were rinsed once with PBS and scraped into
50 ml of sample buffer supplemented with complete protease
inhibitor cocktail (CompleteTM, Boehringer Mannheim, Mann-
heim, Germany) and phosphatase inhibitors (1 mM Na3VO4 and
100 mM NaF) at 4uC. Samples were electrophoretically separated
in 10% SDS-PAGE gels and transferred to nitrocellulose. The
nitrocellulose was incubated with blocking solution [5% w/v
nonfat dry milk, 0.1% Tween-20 in Tris-buffer saline (TBS),
pH 7.4] at room temperature for 1 hour, prior to the addition of
the primary antibodies, anti-Src or anti-phosphoTyrosine-527Src
(Cell Signaling) used according to the manufacturer’s protocol.
The secondary antibody used was goat anti-rabbit IgG conjugated
to HRP (1:2000; Calbiochem). Bands were visualized by
chemiluminescence (PerkinElmer, Boston, MA, USA). The
nitrocellulose was stripped between probing with different
antibodies using 100 mM 2-mercapto-ethanol, 2% w/v SDS in
TBS pH 6.9, at 60uC for 30 minutes.
Quantification of neuronal processes and clusters
Processes of CAD cells were quantified by measuring the soma-
to-tip distance using the 2D-measurement tool of IMARIS 5.0
(Bitplane, Switzerland). A cell was considered differentiated, when
presenting at least one process longer than or equal to 15 mm.
Other criteria used here that characterize differentiated cells,
included number and length of processes, as well as number of
varicosities. The speed of process extension/retraction was
estimated by measuring the initial and final length of a process
at different time points: speed = [final–initial length (mm)/time
(minutes)]. Here, a negative speed value indicates process
retraction. Length and number of dendrites of cortical neurons
were estimated by using the semi-automatic tracing tool of ImageJ
(NeuronJ plug in, NIH).
Thy-1- and F-actin-associated fluorescence intensity in CAD
cells was independently quantified from inverted images of each
fluorescent channel obtained by using ImageJ. Cluster images on
cortical neurons were processed by using the derivative method of
the ImageJ software. This corrective method decreases several optic
artifacts and thereby improves detection and quantification of
cluster-like signals [24,25]. After processing, the number, area and
1-bit masks of both Thy-1 and Src clusters were obtained by using
the ‘‘analyze particles’’ plug-in. Masks were employed to quantify
co-distribution of Thy-1 and Src clusters using OpenView software
(written by Dr. Noam Ziv, Haifa, Israel, see [26]).
Statistical analysis
Results were compared by non-parametric Mann-Whitney
analysis. Statistical significance is indicated in each figure. In all
figures, n is the number of independently performed experiments.
Results
Integrin aVb3 on the cell surface of astrocytes restricts
neurite extension
The effect of aVb3 integrin on neurite outgrowth was first
examined in cell lines. CAD neuron-like cells were seeded over a
monolayer of DITNC1 astrocytes and induced to differentiate by
serum deprivation. When seeded on plastic (Fig. 1A), cellular
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processes of $15 mm in length (a sign of morphological
differentiation together with length of processes, as well as number
of both processes and varicosities) were observed for ,80% of the
cells. In contrast, only ,35% of the cells developed such extended
processes over a monolayer of astrocytes (Fig. 1A). Quantification
of the length of processes showed that neurites were,55% shorter
in CAD cells differentiated over DITNC1 astrocytes (Fig. 1B).
Moreover, the number of both processes and varicosities, beadlike
swellings of these processes, were decreased by ,25% and ,40%,
respectively (Fig. 1C,D). Alternatively, serum-free conditioned
media obtained from astrocyte cultures did not affect any of the
parameters that account for morphological differentiation of CAD
cells on plastic (Fig. 1A–D, black bars). Thus, cell-to-cell contact is
required for DINCT1 astrocytes to restrict neurite extension of
CAD cells.
We next examined whether inhibition of neurite extension was
due to binding between neuronal Thy-1 and astrocytic aVb3
integrin. To this end, differentiation was induced either in the
presence of Thy-1-Fc fusion protein or anti-b3 integrin antibodies.
To avoid integrin cross-linking and astrocyte responses, astrocyte
monolayers were fixed prior to the addition of CAD cells. As
negative controls, monolayers were incubated either with TRAIL-
R2-Fc fusion protein [13] or with antibodies against b1 integrin.
The expression of both aVb3 and b1 integrins have been
previously reported in DITNC1 cells [18]. Neurite outgrowth
over plastic in serum-free medium was largely inhibited by
fixed-astrocytes both in the absence and the presence of the
negative controls (Fig. 1E,F). In contrast, CAD cells readily
extended processes on fixed-astrocytes incubated with either Thy-
1-Fc fusion protein or anti-b3 integrin antibodies (Fig. 1E,F).
To further demonstrate that aVb3 integrin is responsible for
inhibition of neurite outgrowth, CAD cells were differentiated over
fixed-DITNC1 cells that had been transfected with siRNA
targeting the b3 chain of the integrin. As expected, CAD cells
extended neurites on astrocytes lacking the b3 chain (Fig. S2).
Thus, aVb3 integrin present on the surface of DINTC1 astrocytes
inhibits neurite outgrowth of CAD cells, probably through
interaction with Thy-1.
aVb3-Fc effect on neurite extension depends on Thy-1
expression in CAD cells
To further study the possible involvement of aVb3 integrin in
the inhibition of neurite outgrowth, CAD cells were seeded on
aVb3-Fc-coated plastic plates. Compared with cells differentiated
on plastic or supernatant-coated control plates, neurite extension
for CAD cells on aVb3-Fc-coated plates was reduced (Fig. 2A, left
panels). Such reduction was not observed when the aVb3-Fc-
coated plates were pre-incubated with anti-aVb3 integrin antibod-
ies (Fig. 2A, right panels). Quantification of the number of
differentiated cells and length of processes revealed that neurite
outgrowth was decreased by,50%, and the length of processes by
,40%, in comparison to controls, when CAD cells were seeded on
aVb3-Fc-coated plates. Additionally, treatment of aVb3-Fc-coated
plates with antibodies against aV and b3 integrin, but not b1
integrin, before the addition of CAD cells, eliminated the
inhibitory effect of aVb3-Fc on neurite extension (Fig. 2B). No
such effect was observed for control supernatant-coated plates.
Together, these results show that aVb3-Fc is sufficient to restrict
neurite extension of CAD cells that are serum-deprived.
Evidence indicating direct interaction of Thy-1 with aVb3
integrin, competitive inhibition of Thy-1-aVb3 integrin association
in CAD-DITNC1 co-cultures, as well as that the astrocyte
responses triggered by this ligand-receptor alliance are due to
Thy-1-engagement of aVb3 integrin has been previously reported
[13–18]. Nevertheless, whether this interaction may be responsible
for aVb3-mediated inhibition of neurite extension remained to be
shown. To test this, we silenced Thy-1 expression by stable
delivery of specific shRNA constructs (shRNA Thy-1) using
lentiviral vectors. A lentiviral vector containing an shRNA specific
for Luciferase was employed as a control (shRNAluc control). Thy-
1 expression was evaluated by Western blotting and immunoflu-
orescence analysis. With all four shRNA constructs tested, Thy-1
protein levels were greatly reduced compared to shRNAluc
control-transduced cells (Fig. 2C). For immunofluorescence,
shRNA Thy-1-transduced cells not only presented almost
undetectable Thy-1 levels, but also longer protrusions, consistent
with the interpretation that they lack a neurite-outgrowth inhibitor
(Fig. 2C). Using both shRNA Thy-1 and shRNAluc control cells,
the effect of aVb3-Fc-coated plates on differentiation of these cells
was evaluated. Similar to wild-type CAD cells (Fig. 2B),
morphological differentiation of shRNAluc control cells declined
from ,80% on non-treated plastic to ,40% on aVb3-Fc-coated
plates (Fig. 2D). Importantly, shRNA Thy-1 cells were completely
resistant to the inhibitory effect of aVb3-Fc on neurite outgrowth,
and the percentage of differentiated cells and the length of
processes were indistinguishable from those of control cells grown
on plastic (Fig. 2D). To discard OFF-target effects of the shRNA,
CAD cells transduced with different shRNA Thy-1 constructs
were also tested. In these cells, aVb3-Fc showed no effect on
neurite outgrowth (Fig. S3). These results implicate Thy-1-aVb3
integrin interaction in the inhibition of neurite outgrowth in CAD
cells.
aVb3-Fc suppresses dendrite extension in primary cortical
neurons
During morphological polarization, Thy-1 expression is re-
stricted to the somato-dendritic compartment in the rodent brain
[27]. This was corroborated analyzing Thy-1 presence in soma
and dendrites (MAP2-positive), as well as in axons (Tau-positive) of
cortical neurons undergoing morphological differentiation after 4
to 7 days in culture in vitro. Thy-1 was detected forming clusters at
the cell surface of both soma and dendrites after 4 days. Greater
number of clusters was observed after 7 days in culture (Fig. 3A).
In contrast, there was no detectable Thy-1 signal in growing axons
after 4 days (Fig. 3A) or 6 days (not shown). However, after 7 days
in culture, a few Thy-1 clusters were observed in axons (Fig. 3A).
Coincident with low Thy-1 presence in axons, no changes in
axonal growth in the presence of aVb3 integrin were observed (not
shown), Thus, the effect of aVb3 integrin was further analyzed by
evaluating dendrite outgrowth.
After exposing these neurons to aVb3-Fc-containing superna-
tants, dendrites were poorly developed (Fig. 3B, inverted image).
Indeed, aVb3-Fc-containing supernatant decreased by ,50% the
length of dendrites and by ,30% the number of dendrites per
neuron, compared with non-treated neurons (Fig. 3C). Specificity
of aVb3-Fc-mediated effects was controlled by using aVb3-Fc-
depleted supernatants (DS), supplemented or not with TRAIL-
R2-Fc (TRAIL-R2-Fc). Dendrite outgrowth was not affected in
neurons exposed to both types of control supernatants (Fig. 3B,C).
To further implicate surface Thy-1 in the aVb3-Fc-induced
inhibition of dendrite outgrowth, GPI-anchored proteins were
cleaved from the cell surface by PI-PLC treatment, before the
addition of aVb3-Fc. PI-PLC treatment prevented aVb3-Fc-
induced inhibition of dendrite outgrowth (Fig. 3D,E). Taken
together, these results suggest that, dendrite extension of primary
cortical neurons is reduced in a Thy-1-dependent manner in the
presence of the aVb3 integrin.
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Figure 1. Integrin aVb3 expressed by DITNC1 astrocytes inhibits neurite extension of CAD cells. (A–D) Quantification of four different
morphological parameters using IMARIS software (Bitplane, Switzerland) of bright-field microscopy images of CAD cells seeded over plastic, seeded
over plastic in serum-free medium previously conditioned by DITNC1 cells for 24 hours (black bars) or over a monolayer of DITNC1 astrocytes in
serum-free medium. (A) Percentage of differentiated CAD cells with processes $15 mm; (B) length of the processes extended by differentiated cells,
expressed as a percentage of the control over plastic; (C) number of processes in 100 differentiated cells and (D) number of varicosities per 100
differentiated cells. (E,F) CAD cells seeded over fixed-astrocyte monolayers were induced to differentiate. To block aVb3 integrin, fixed-cells were
incubated with recombinant Thy-1-Fc or antibodies against b3 integrin. TRAIL-R2-Fc or antibodies against b1 integrin were used as controls. Co-
cultures were photographed (E) and the percentage of differentiated CAD cells (F) was quantified as in (A). Arrows in E indicate axon-like neurites
growing over the DITNC1 mololayer. All graphs show mean+s.e.m. determined from at least 100 cells per condition; n = 3. **P,0.01 or *P,0.05
compared with control cells seeded over plastic. #P,0.05 compared with their respective control.
doi:10.1371/journal.pone.0034295.g001
Figure 2. Recombinant aVb3-Fc is sufficient to inhibit neurite extension of wild type CAD cells but not of CAD Thy-1(2) cells. (A, B)
CAD cells were seeded over plastic, plates pre-coated with aVb3-Fc fusion protein or with control supernatants. Where indicated, antibodies against
aV and b3 chains were added. (A) DIC pictures obtained 24 hours after inducing process extension over the different substrates. (B) Images were
analyzed using IMARIS software. The percentage of differentiated CAD cells (upper panel) and the length of processes extended by these cells (lower
panel) are shown. Quantification of additional controls, such as antibody vehicle and anti-b1 antibodies are also shown. (C) CAD cells lacking Thy-1,
generated with Thy-1-targeted shRNA (1–4) and the corresponding control (Luc), were assessed by Western blotting. Actin was used as loading
control (upper panels). Thy-1 silencing was further characterized by immunofluorecence (lower panels) staining for Thy-1 (green) and polymerized
actin (red). Bar = 15 mm. (D) CAD cells lacking Thy-1 or control cells were seeded over plastic or over aVb3-Fc-coated plates. Neurite extension was
quantified as in (B). Graphs show mean+s.e.m. determined from at least 100 cells per condition; n = 3. *P,0.05 compared with respective control cells
seeded over plastic. #P,0.05 compared with CAD cells seeded on aVb3-Fc pre-treated with antibodies against b1 subunit. +P,0.05 CAD Thy-1(2)
compared with shRNA control cells seeded on aVb3-Fc.
doi:10.1371/journal.pone.0034295.g002
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Thy-1 accumulates in collapsed terminals of aVb3-Fc-
treated CAD cells
Thy-1 is reportedly absent in axons during early neuronal
development [2,27]. Later, Thy-1 is highly expressed, but
excluded from F-actin-positive segments in stabilized axons of
mature neurons [28]. Thus, Thy-1 and F-actin distribution were
evaluated in axon-like neurites of differentiated CAD cells by
immunofluorescence analysis and confocal microscopy. As report-
ed for primary neurons, Thy-1 was excluded from F-actin-positive
segments and its presence was scarce at the tips of CAD cell
neurites at 24 and 72 hours of differentiation (Fig. 4A).
Then, CAD cells were employed to study aVb3-Fc-mediated
effects on Thy-1 localization, since the ultra structure of axon-like
processes of differentiated CAD cells resembles that of primary-
neuron axons [19]. Thy-1- and F-actin-associated fluorescence
was evaluated after 24 hours, because processes were simpler and
more reminiscent of axons at this time point in CAD cells.
Histograms of fluorescence intensity of separated or merged
fluorophores are presented for one axon-like neurite (Fig. 4B) or as
the mean of several elongated processes (Fig. 4C). Results obtained
with cells treated with control supernatants confirmed that Thy-1
was abundant in segments where F-actin content was low, and vice
versa (control panels, Fig. 4B,C). Importantly, Thy-1 was found
accumulated in collapsed tips of cells treated with aVb3-Fc for
30 minutes (aVb3-Fc panels, Fig. 4B,C).
Additionally, terminal collapse preceded rapid neurite retrac-
tion, as observed using DIC optic-coupled live cell monitoring
photographed during 75 minutes. In control differentiated CAD
cells, neurites did not retract during these 75 minutes (Fig. 5A),
whereas those exposed to aVb3-Fc showed fast and steady
Figure 3. Recombinant aVb3-Fc inhibits extension of dendrites in cortical neurons. (A) Cortical neurons, cultured for 4 and 7 days of culture
in vitro were stained for Thy-1 (red), MAP-2 (soma/dendrite staining, blue) and Tau (axon staining, green). Arrows indicate some areas with Thy-1
staining. Asterisks label Thy-1-negative axons. (B–E) Neurons, cultured for 4–5 days in vitro were treated with supernatants containing aVb3-Fc fusion
protein (aVb3-Fc), aVb3-Fc-depleted supernatants (DS), aVb3-Fc-depleted supernatants supplemented with TRAIL-R2-Fc (TRAIL-R2-Fc), or non-
treated (NT) for 72 hours. Where indicated, 1 U/ml of PI-PLC was added prior to integrin addition (D,E). (B,D) Inverted fields of MAP-2 fluorescence
images that were used to count neurons and evaluate dendrite length. (C,E) Quantification of two different morphological parameters performed
using Neuro ImageJ software. Results shown are the mean+s.e.m. of 720 neurons from three independent experiments (C) or 240 neurons from two
independent experiments (E). *P,0.05 compared with DS condition.
doi:10.1371/journal.pone.0034295.g003
Figure 4. Recombinant aVb3-Fc induces Thy-1 redistribution and process retraction in differentiated CAD cells. CAD cells were seeded
on coverslips in complete media for 12 hours. Differentiation was induced or not (undifferentiated, UD), by changing to serum-free medium for 1, 24
or 72 hours. Then, cells were stained for Thy-1 (green, arrowheads) and polymerized actin (red). Samples were visualized by confocal microscopy.
Images representative of those obtained in 5 independent experiments are shown. Magnification bars = 20 mm. (B,C) CAD cells differentiated for
24 hours were treated with supernatants containing (aVb3-Fc) or not (control) aVb3-Fc fusion protein. Cells were immunostained for Thy-1 (green)
and polymerized actin (red). Fluorescence intensities of one (B) or 100 (C) neuronal-like processes were quantified by densitometric analysis using
ImageJ software. Merged colors are shown in yellow (B). Average fluorescence intensities of the red (F-actin) and green (Thy-1) staining were
obtained for control and aVb3-Fc treated cells (C). To compare several processes of different lengths, each fluorescence profile was fitted to a 0–100
scale (n = 5).
doi:10.1371/journal.pone.0034295.g004
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retraction (Fig. 5B). The speed of neurite retraction, estimated as
indicated in Materials and Methods, was 20.4860.13 mm/
minutes in aVb3-Fc-treated CAD cells. To the contrary, those in
control condition grew at a speed of 0.0260.03 mm/minutes.
Therefore, aVb3-Fc not only induces Thy-1-dependent suppres-
sion of neurite outgrowth in CAD cells induced to differentiate,
but also triggers redistribution of Thy-1 and axon-like neurite
retraction in already differentiated CAD cells.
aVb3-Fc-induced Thy-1 retraction of axonal terminals of
cortical neurons
After morphological polarization of neurons in vitro, the axons
look thin and uniform in diameter and Thy-1 is mainly present in
the axonal-somatic compartment [29]. Thus, we evaluated aVb3-
Fc-mediated effects on Thy-1 distribution and axon morphology
in mature and polarized cortical neurons. Neurons cultured for
12–15 days in vitro were treated with aVb3-Fc-depleted or aVb3-Fc-
containing supernatants and Tau-positive/MAP-2 negative stain-
ing was used to identify axonal processes (not shown). Typically, a
modest but detectable Thy-1 presence was observed in ,90% of
the extended-stabilized axon cones (Fig. 6A,B; DS). Importantly,
Thy-1 immune-reactivity accumulated in rounded, retracted tips
of neuronal cultures treated with aVb3-Fc (Fig. 6A,B; aVb3-Fc).
Indeed, quantification showed that ,55% of Thy-1 positive
axonal terminals had collapsed in aVb3-Fc-treated neurons
(Fig. 6C). Thus, in mature cortical neurons, aVb3-Fc triggers
Thy-1 accumulation at the end of the processes and axonal
growth-cone collapse, as similarly observed for axon-like neurites
in differentiated CAD cells (Fig. 4).
Based on the absence of a defined ligand, Thy-1 clustering has
been artificially induced by using aggregating antibodies in
different cell types [9,11,30]. Thus, to test the possibility that the
aVb3 integrin may be functionally more effective upon cross-
linking, aVb3-Fc molecules were bound to Protein A. Indeed, the
percentage of axonal terminals that collapsed in the presence of
aVb3-Fc-Protein A complexes increased to ,80% (Fig. 6C)
Figure 5. Time course of process retraction induced by recombinant aVb3-Fc. CAD cells were plated and differentiation was induced as
indicated in Fig. 4A for 72 hours. Differentiated CAD cells were exposed to (A) supernatants depleted of recombinant aVb3-Fc (Control) or (B)
supernatants containing aVb3-Fc for 75 minutes (aVb3-Fc). Cell morphology was continuously monitored using a digital camera coupled to a
microscope with a water-immersion objective and DIC optics. Images captured every 2.5 minutes are shown. White arrowheads indicate the position
of the tip of the neurite at time point zero, whereas the black arrowhead shows the end of the trajectory after 75 minutes in (A) or after 12.5, 27.5,
42.5, 57.5 and 75 minutes in (B). A representative result of 5 independent retraction experiments is shown.
doi:10.1371/journal.pone.0034295.g005
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suggesting that increased aVb3 integrin valency favors the axonal
retraction process by clustering neuronal receptors.
To confirm Thy-1 involvement in integrin-induced axonal
terminal collapse, neurons were treated with PI-PLC before the
addition of aVb3-Fc and axons were stained with anti-Tau
antibodies. As expected, aVb3-Fc induced Thy-1 accumulation
in the Tau-positive neuronal processes (Fig. 6D). Importantly,
even in the presence of aVb3-Fc, extended axon terminals were
observed in PI-PLC-pretreated neurons with reduced Thy-1
(Fig. 6D), supporting the idea that aVb3-Fc effects on growth
cone collapse depends on Thy-1 presence.
aVb3-Fc-induced Thy-1 clustering on the plasma
membrane of neurons
Bearing in mind the previous results, the possibility that the
aVb3 integrin may induce clustering of its neuronal receptor Thy-1
was tested. For this purpose, mature neurons were exposed for
short periods of time (15–60 minutes) to different supernatants and
after fixation, cell surface Thy-1 was identified with antibodies
under non-permeabilizing conditions (see Materials and Methods).
In non-treated (not shown) or in control neurons treated with
depleted supernatants (DS), numerous small clusters were detected
on the cell surface (left panel, Fig. 7A). The number and size of
these clusters increased significantly in the presence of aVb3-Fc for
15 minutes (right panel, Fig. 7A). For processes of neurons
exposed to aVb3-Fc-depleted supernatants (DS), ,450 clusters
with an area of 20–100 pix2 were detected after 15–60 minutes
(Fig. 7B). For the same area, the number of clusters increased to
,950 in the presence of aVb3-Fc after 15 minutes (Fig. 7B). The
number of clusters decreased after longer treatments (compare
aVb3-Fc at 15 minutes with 30 and 60 minutes in Fig. 7B).
Cumulative distribution of cluster sizes to analyze the frequency
of appearance of different clusters was also estimated. However,
no changes in cumulative distribution of cluster sizes were
observed in neurons treated with aVb3-Fc for 15 or 60 minutes
(not shown) indicating that aVb3-Fc increases the number of a
wide-range of Thy-1 clusters. As expected, the number of clusters
significantly increased upon incubation with Protein-A (Fig. 7C).
Additionally, larger clusters (100–200 pix2) were observed in
neurons incubated with aVb3-Fc-Protein A (Fig. 7C), and the
presence of aVb3-Fc was detectable in such large Thy-1 clusters
(Fig. 7D). Importantly, increased clustering correlated with the
axonal terminal retraction found in aVb3-Fc- and aVb3-Fc-Protein
A-treated neurons (Fig. 6). Thus, Thy-1 clustering is likely to
Figure 6. Collapse of axonal terminals of cortical neurons induced by recombinant aVb3-Fc. (A, B) Differentiated cortical neurons, 12–15
days in culture in vitro, were treated with supernatants containing aVb3-Fc fusion protein (aVb3-Fc) or with aVb3-Fc-depleted supernatants (DS),
supplemented or not with Protein A. Then, neurons were fixed and immunostained for Thy-1 (A–D) and Tau protein (D) and photographed using
conventional fluorescence microscopy. (B) Digital zoom was applied to marked areas (red squares in A) and indicated areas were inverted by gray-
tone scaling using ImageJ. (C) Quantification of Thy-1-positive retracted axonal terminals in neurons for each condition is plotted as a percentage of
total cells. NT, non-treated neurons; DS, aVb3-Fc-depleted supernatants; aVb3-Fc, aVb3-Fc-containing supernatant; PA, Protein A; aVb3-Fc+PA,
aVb3-Fc-containing supernatant supplemented with Protein A (see Methods). Graphs show means+s.e.m. from at least 25 neurons per condition,
n = 4. *, &, P,0.05 compared to their respective control. (D) Representative axonal terminals are shown from neurons treated with aVb3-Fc-depleted
supernatants (DS); aVb3-Fc-containing supernatant (aVb3-Fc); or 1 U/ml of PI-PLC added prior addition of aVb3-Fc-containing supernatants (PI-PLC/
aVb3-Fc). Arrows point to Thy-1 clusters in axon and growth cone. Asterisk indicates a retracted axonal terminal.
doi:10.1371/journal.pone.0034295.g006
Integrin-Thy-1 Binding Retracts Neuronal Processes
PLoS ONE | www.plosone.org 10 March 2012 | Volume 7 | Issue 3 | e34295
represent the first event in the signaling cascade triggered by aVb3
integrin in neurons.
aVb3-Fc induces Thy-1-Src co-distribution and Src
inhibition in cortical neurons
Clustering of cell surface Thy-1 with antibodies is known to
induce Src kinase recruitment to Thy-1-enriched microdomains at
the plasma membrane [30–32]. Thus, possible effects of aVb3-Fc
on Src localization were evaluated by immunofluorescence. After
15 minutes of treatment with aVb3-Fc, staining of Src co-
distributed with Thy-1 clusters in axons (Fig. 8A). Thy-1-Src
cluster co-distribution was analyzed by creating 1-bit masks for
both Thy-1 (Thy-1 mask, Fig. 8A) and Src (Src mask, Fig. 8A)
fluorescence channels. Co-distribution of Thy-1 and Src clusters
increased ,2.5-fold in integrin-treated neurons compared to
control neurons (Fig. 8B). The number of clusters containing Thy-
1-only also increased significantly, whereas the number of Src-only
clusters did not change with the treatment (Fig. 8B).
Available evidence indicates that clustering of Thy-1 not only
recruits Src, but also modifies its activity [9,31]. To evaluate this
possibility, inhibition-associated Src phosphorylation at Tyrosine-
527 (SrcpTyr527) was assessed by immunoblotting. Analysis of
SrcpTyr527 after treatment with aVb3-Fc revealed a significant
increase after 15 minutes, which decreased thereafter (Fig. 8C,D).
Therefore, both Thy-1 clustering and Src inactivation reach their
highest values at roughly the same time (,15 minutes) after
Figure 7. Soluble aVb3-Fc induces Thy-1 cluster formation on the plasma membrane of living cortical neurons. Mature cortical neurons
were treated with supernatants containing aVb3-Fc fusion protein (aVb3-Fc) supplemented or not with Protein A (PA), or with aVb3-Fc-depleted
supernatants (DS) for 15–60 minutes. Neurons were immunostained for Thy-1 only (A) or for Thy-1 and aVb3-Fc (D). (A and D) Thy-1 clusters (arrows
in A) and co-localization with bound aVb3-Fc (arrows in D) of representative images captured with an epifluorescence microscope are shown.
Bar = 20 mm. (B) Data plotted as time versus the number of clusters were obtained from images processed using ImageJ. Ranges of cluster size from
20 to 100 pix2 (1 pix2 = 0.01 mm2). (C) Data plotted as a range of cluster sizes versus the number of clusters for each indicated condition. Results show
mean+s.e.m. (12 neurons per condition, n = 6). **P,0.01 and ***P,0.001 compared with their respective control cells in DS at time 15 minutes.
#P,0.05 between aVb3-Fc-Protein A and aVb3-Fc (D).
doi:10.1371/journal.pone.0034295.g007
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stimulation. Additionally, Thy-1 and Src co-distributed in clusters
within the plasma membrane, suggesting that all these events
might constitute an interconnected signaling cascade triggered by
aVb3 integrin in primary neurons.
Discussion
Here, we describe a novel function for Thy-1-aVb3 integrin
interaction between neurons and astrocytes. Our studies demon-
strate that aVb3 integrin, present on the astrocyte surface, is
sufficient to trigger a Thy-1-mediated functional effect in neurons.
We have previously described that the Thy-1-aVb3 integrin
receptor interaction mediates neuron-to-astrocyte communication
and signaling events that change astrocyte morphology [17,18].
Rather intriguingly, aVb3 integrin is now shown to represent a
ligand for Thy-1, which upon interaction triggers dramatic
changes in neurons, including inhibition of neurite outgrowth
and axonal retraction. Thus, a function induced by an endogenous
ligand for this highly abundant glycoprotein is described in
neurons. Taken together, results shown here, in conjunction with
our previous findings describe a novel mechanism of bidirectional
neuron-to-astrocyte communication in vitro.
Thy-1 possesses an integrin-binding site (RLD) in its primary
sequence that is directly and specifically recognized by aVb3
integrin receptor in astrocytes [13,15–18]. Evidence supporting
the existence of this interaction was obtained using Thy-1(RLD)-
Fc, Thy-1(RLE)-Fc, and aVb3-Fc recombinant fusion proteins in
Surface Plasmon Resonance experiments, as well as using cell-to-
cell and cell-to-molecule adhesion assays [13,15–18]. Thus, those
and the present findings that include treatment with specific
antibodies, competition with recombinant fusion proteins and the
use of Thy-1- or b3 integrin-deficient cells, indicate that aVb3
integrin-induced inhibition of neurite extension is unequivocally
dependent on its binding to Thy-1 and signaling events triggered
in neurons as a consequence of this interaction.
The presence of a putative ligand for Thy-1 on the cell surface
of primary astrocytes maintained in culture during 1–2 months in
vitro was reported earlier [5,33]. Indeed, Thy-1(+) but not Thy-
1(2) NG115 cells cultured over these long-lasting primary
astrocyte cultures, develop less and shorter neurites. Accordingly,
our results indicate that DITNC1 astrocytes inhibit neurite
outgrowth in a manner that depends on aVb3 integrin and Thy-
1 (Fig. 1 and Fig. S2), and that neurons lacking Thy-1, but not
Thy-1(+) cells, grow their processes over aVb3-coated plates
(Fig. 2D and Fig. S3). Thus, most likely aVb3 integrin represents
an astrocyte surface-bound primary messenger that inhibits the
growth of neuronal processes by direct contact with Thy-1.
Establishing Thy-1-mediated signal transduction has been
complicated by the fact that it is a GPI-anchored protein that
does not span the membrane bilayer. Given its localization in
cholesterol-rich micro-domains [11,12], non-canonical signaling
mechanisms, including changes in lateral diffusion and Thy-1
Figure 8. aVb3-Fc induces Thy-1/Src co-distribution and Src
inhibition in cortical neurons. Mature cortical neurons were treated
with supernatants containing aVb3-Fc fusion protein (aVb3-Fc) or with
aVb3-Fc-depleted supernatants (DS) for 15–75 minutes. (A) After
15 minutes, neurons were fixed and immunostained for Thy-1 (green)
or total Src kinase (red). Samples were photographed using a
conventional fluorescence microscope. Clusters were identified creating
a 1-bit mask for each fluorescent channel using Image J software. Black
arrows indicate Thy-1 clusters co-distributed with Src clusters. Green
arrows indicate Thy-1-only, red arrows Src-only clusters. (B) Quantifica-
tion of cluster distribution as indicated. **P,0.01, *P,0.05 compared
with number of Thy-1/Src co-distributed clusters in DS. #P,0.05
compared to Thy-1/Src co-distributed clusters in aVb3-Fc. Results
averaged from three independent experiments analyzing 5 axonal
segments per experiment are shown. (C) At different time points,
neurons were lyzed and analyzed by Western blotting. Blots for Src
phosphorylated at tyrosine 527 (SrcpTyr527) and total Src (Srctotal) are
shown. (D) Numerical values were obtained by scanning densitometry
from three independent experiments and are expressed as phosphor-
ylated/total Src ratio for each time point. *P,0.05 compared to time= 0.
n.s.d. indicates non-significant differences compared to time=0.
doi:10.1371/journal.pone.0034295.g008
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clustering in lipid rafts, are likely to play a role [9,30]. In both
neuronal and non-neuronal cells, changes observed upon cross-
linking Thy-1 with antibodies have been associated with signaling
via Src family kinases [9,30,32], intracellular calcium elevation
[34] or shedding of Thy-1 from the plasma membrane [35].
Importantly, aVb3-Fc triggered Thy-1 accumulation at the ball-
shaped terminals was observed (Fig. 4) suggesting that, upon
ligand engagement, Thy-1 redistributes and/or clusters to drive
selective retraction of neuritic terminals. Considering that anti-
Thy-1 antibodies require 4-fold more time to induce shedding
than aVb3-Fc to induce redistribution of Thy-1, and that shedding
is suggested to stimulate neurite extension [35]; we consider it
highly unlikely that aVb3-induced Thy-1 shedding was responsible
for the observed neurite retraction or inhibition of neurite
extension.
Additionally, transmembrane transducer proteins like Csk-
binding protein (CBP) are proposed to mediate ligand-induced
signaling via Thy-1 in fibroblasts [30]. The transducer serves to
connect signaling molecules attached to the outer-leaflet of the
plasma membrane with those located in the inner-leaflet of the
bilayer [11,12], such as Src. Our results show that signaling
initiated by aVb3 integrin ligand coincides temporarily with
clustering of Thy-1 and Src molecules, as well as with inhibition of
Src in living cortical neurons (Figs. 6, 7 and 8). Thus, Thy-1
aggregation is likely to represent the first step of the signaling
cascade triggered by aVb3 integrin, which includes Src inactiva-
tion. Interestingly, it has been demonstrated that Src-RhoA
GTPase axis is critically involved in the regulation of neurite
outgrowth [36]. Currently, studies are underway in our laboratory
to address these interesting mechanistic questions.
Thy-1 knockout mice show defects to socially transmit food
related cues [37] and a deficiency in synaptic transmission, such as
impaired long-term potentiation [38]. Other studies performed
with mice carrying a targeted deletion of the Thy-1 gene, show no
increase in axon regeneration after two months of a spinal lesion in
the corticospinal tract [39]. Nonetheless, given the large number of
molecules that inhibit axonal repair, which are present post-injury
at the site of lesion, treatments targeting only individual molecules
have been modestly successful in achieving functional nerve repair.
This has given rise to the notion that combined strategies, which
target multiple factors involved in limiting axonal repair are
required [40,41]. Given the abundance of Thy-1 in neurons and
the inherent presence of reactive astrocytes in the post-injury zone,
the events described here are likely to contribute to inefficient
CNS repair. Thus, this Thy-1-aVb3 integrin pair constitutes a new
target for combined therapeutic interventions.
Inhibitory molecules that are up regulated upon injury-induced
astrogliosis, not only block initial axonal sprouting, but also
promote the formation of clubbed endings, characteristic of axonal
retraction [42,43]. Interestingly, we describe that aVb3 integrin
present in astrocytes induced the retraction of neuritic process
terminals (Figs. 5 and 6). Moreover, we also found that Thy-1
localizes to the tip of the axonal terminals upon ligand
engagement, likely accounting for its ability to block re-grow
and promote retraction of neuronal processes. Thus, consistent
with a putative inhibitory role for Thy-1 in regeneration and
repair, if aVb3 integrin is up regulated by astrocytes during
astrogliosis, as it has been found in neurodegenerative diseases
[44,45], under ischemia insults [46,47], or in malignant glioma
cells [48], its interaction with the abundantly expressed neuronal
Thy-1 could account for aVb3 integrin-induced axonal retraction
and formation of bulbous terminals in injured tissue.
Accordingly, aVb3 integrin levels are nearly undetectable in late
fetal or postnatal astrocytes, in short-term cultures or in mature
astrocytes [48–51]; thus, the aVb3 integrin-Thy-1 interaction is not
expected to affect neurite outgrowth in adult healthy brains.
Therefore, although the enigma of the orphan Thy-1 receptor has
been unveiled, the actual in vivo role of the aVb3 integrin-Thy-1
interaction in brain health and disease remains an important issue
to be resolved.
In summary, here we show that aVb3 integrin interacts with
Thy-1 in neurons to induce inhibition of neurite extension, as well
as retraction of neuronal processes. Thus, evidence for a Thy-1
function triggered by its endogenous ligand is presented here for
the first time and agrees with earlier observations suggesting that
Thy-1 acts as a receptor for astrocyte-associated ligands leading to
inhibition of axonal growth [3,5].
Supporting Information
Figure S1 Immunodetection of Thy-1 clusters on the
surface of neuronal plasma membrane. (A) In the left
panels, neurons were cultured for 21 days in vitro fixed with 4% of
p-formaldehyde at room temperature (1), stained with mouse (ms)
or guinea pig (gp) anti-MAP-2 primary antibodies, followed by
incubation with a Cy3-conjugated donkey anti-mouse IgG or a
FITC-conjugated donkey anti-guinea pig IgG, and photographed
(2). In the right panels, cells from the same coverslips were
permeabilized with 0,1% Triton X-100 (3), and stained again with
anti-MAP-2 antibodies of different origin. Note that without
permeabilization, antibody diffusion into the neurons was
minimal. (B) Live neurons were treated with 1 U/ml of PI-PLC
and, after fixing and permeabilizing, stained for Thy-1 and MAP-
2. Top panels show neurons treated with heat-inactivated PI-PLC
(NT); bottom panels, neurons treated with PI-PLC (+PI-PLC).
After PI-PLC-treatment Thy-1 clusters are no longer detected on
the neuronal plasma membrane, whereas MAP-2 was clearly
visible.
(TIF)
Figure S2 Silencing of b3 integrin in DITNC1 cells
allows CAD cell differentiation over DITNC1 monolayer.
DITNC1 astrocytes were transfected with 3 different pre-designed
siRNA for b3 integrin (500 nM, Ambion), 59R39 GCUACU-
CAUCACCAUUCAU GGUGGAGGAUUACCUGUA,
GGAGCAAUCUUUCACUAUU, using siPORT Amine (Am-
bion). (A) Silencing of b3 integrin was evaluated by Western Blot
analysis with anti-b3 integrin antibody (Abcam). Scrambled siRNA
(Santa Cruz, Biotechnology) was used as a negative control. Actin
was evaluated to test sample loading. (B) After 48 hours of
transfection, 90% confluent astrocyte monolayers were fixed with
4% p-formaldehyde in 100 mM PIPES pH 6.8, 0.04 M KOH,
2 mM EGTA and 2 mM MgCl2 for 15 minutes at room
temperature. Then, 86104 neuronal CAD cells were added to
fixed-astrocyte monolayers. Next day, cells were washed with PBS
and differentiation of CAD cells in serum-free medium was
induced for 24 hours. Quantification of differentiated cells was
performed using the plug in NeuroJ from ImageJ software. Results
shown are the mean+s.e.m. (100 neurons per condition, n = 3).
**P,0.01 compared with control condition.
(TIF)
Figure S3 Transduction with different shRNA con-
structs targeting Thy-1 produces resistance to aVb3-Fc-
induced neurite outgrowth inhibition in CAD cells. CAD
cells were transduced using lentivirus containing shRNA2,
shRNA4 or control shRNAluc as described for Fig. 2C. Then,
transduced cells were plated on aVb3-Fc-coated or control plates
and tested for neurite outgrowth after 24 hours. (A) Representative
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images of each condition are shown (B) Length of processes was
quantified as mentioned in Material and Methods. Data are
mean+SD of two independent experiments (,80 cells per
condition).
(TIF)
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